Latest Breaking News On - Access global inc - Page 1 : comparemela.com

NovAccess Global Inc (OTCMKTS:XSNX) Short Interest Down 84 6% in May

NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 400 shares, a decline of 84.6% from the April 30th total of 2,600 shares. Based on an average daily trading volume, of 869,000 […]

United statesChagrin fallsNovaccess global incNovaccess globalGet free reportAccess globalAccess global incNovaccess global daily

Critical Contrast: Protagonist Therapeutics (NASDAQ:PTGX) & NovAccess Global (OTCMKTS:XSNX)

Critical Contrast: Protagonist Therapeutics (NASDAQ:PTGX) & NovAccess Global (OTCMKTS:XSNX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Chagrin fallsUnited statesProtagonist therapeutics incNovaccess global incNovaccess globalGet free reportProtagonist therapeuticsProtagonist therapeuticAccess globalGiven protagonist therapeuticAccess global incNovaccess global daily

Analyzing NovAccess Global (OTCMKTS:XSNX) and Protagonist Therapeutics (NASDAQ:PTGX)

Analyzing NovAccess Global (OTCMKTS:XSNX) and Protagonist Therapeutics (NASDAQ:PTGX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesChagrin fallsNovaccess global incProtagonist therapeutics incNovaccess globalGet free reportProtagonist therapeuticsGiven protagonist therapeuticProtagonist therapeuticAccess globalAccess global incNovaccess global daily

Head to Head Analysis: Protagonist Therapeutics (NASDAQ:PTGX) versus NovAccess Global (OTCMKTS:XSNX)

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) and NovAccess Global (OTCMKTS:XSNX – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Institutional & Insider Ownership 98.6% of Protagonist […]

United statesChagrin fallsNovaccess global incProtagonist therapeutics incProtagonist therapeuticsGet free reportNovaccess globalGiven protagonist therapeuticAccess globalAccess global incProtagonist therapeutics dailyNasdaq ptgxStock comparisonStock analysis

NovAccess Global Inc (OTCMKTS:XSNX) Short Interest Down 85 7% in January

NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 400 shares, a drop of 85.7% from the December 31st total of 2,800 shares. Based on an average daily volume of 1,208,200 shares, […]

United statesChagrin fallsNovaccess global incNovaccess globalGet free reportAccess globalAccess global incNovaccess global dailyOtcmkts xsnx